GOLDMAN SACHS GROUP INC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,891,011
+64.4%
395,609
+46.2%
0.00%
Q2 2023$1,150,224
-31.0%
270,641
-13.7%
0.00%
Q1 2023$1,666,114
-24.8%
313,769
-11.1%
0.00%
Q4 2022$2,216,193
-63.0%
352,897
-37.9%
0.00%
-100.0%
Q3 2022$5,996,000
+687.9%
568,329
+305.0%
0.00%
Q2 2022$761,000
-70.3%
140,318
-49.8%
0.00%
-100.0%
Q1 2022$2,566,000
+436.8%
279,458
+780.9%
0.00%
Q4 2021$478,00031,7230.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$11,316,00014.13%
Memorial Sloan Kettering Cancer Center 674,196$16,093,00010.03%
PFM Health Sciences, LP 4,092,309$88,176,0002.59%
CloudAlpha Capital Management Limited/Hong Kong 305,000$7,280,0002.15%
Monashee Investment Management LLC 449,377$10,727,0001.98%
Avidity Partners Management LP 2,474,067$59,056,0001.31%
Green Alpha Advisors, LLC 32,836$784,0000.54%
Tekla Capital Management LLC 699,377$15,621,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 200,000$4,774,0000.40%
FARALLON CAPITAL MANAGEMENT LLC 2,963,448$70,738,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders